Výsledky vyhledávání - Nobuya Inagaki

Upřesnit hledání
  1. 1
    Role of sodium‐glucose transporters in glucose uptake of the intestine and kidney

    Role of sodium‐glucose transporters in glucose uptake of the intestine and kidney Autor Norio Harada, Nobuya Inagaki

    Vydáno 2012
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  2. 2
    Renal sodium glucose cotransporter 2 inhibitors as a novel therapeutic approach to treatment of type 2 diabetes: Clinical data and mechanism of action

    Renal sodium glucose cotransporter 2 inhibitors as a novel therapeutic approach to treatment of type 2 diabetes: Clinical data and mechanism of action Autor Yoshihito Fujita, Nobuya Inagaki

    Vydáno 2014
    Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  3. 3
    Subunit stoichiometry of the pancreatic β‐cell ATP‐sensitive K<sup>+</sup> channel

    Subunit stoichiometry of the pancreatic β‐cell ATP‐sensitive K<sup>+</sup> channel Autor Nobuya Inagaki, Tohru Gonoi, Susumu Seino

    Vydáno 1997
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  4. 4
    MgADP Antagonism to Mg2+-independent ATP Binding of the Sulfonylurea Receptor SUR1

    MgADP Antagonism to Mg2+-independent ATP Binding of the Sulfonylurea Receptor SUR1 Autor Kazumitsu Ueda, Nobuya Inagaki, Susumu Seino

    Vydáno 1997
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  5. 5
    Non-invasive Beta-cell Imaging: Visualization, Quantification, and Beyond

    Non-invasive Beta-cell Imaging: Visualization, Quantification, and Beyond Autor Takaaki Murakami, Hiroyuki Fujimoto, Nobuya Inagaki

    Vydáno 2021
    Získat plný text Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  6. 6
    Cellular Senescence in Diabetes Mellitus: Distinct Senotherapeutic Strategies for Adipose Tissue and Pancreatic β Cells

    Cellular Senescence in Diabetes Mellitus: Distinct Senotherapeutic Strategies for Adipose Tissue and Pancreatic β Cells Autor Takaaki Murakami, Nobuya Inagaki, Hiroshi Kondoh

    Vydáno 2022
    Získat plný text Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  7. 7
    Role of Reactive Oxygen Species in Glucose Metabolism Disorder in Diabetic Pancreatic β-Cells

    Role of Reactive Oxygen Species in Glucose Metabolism Disorder in Diabetic Pancreatic β-Cells Autor Eri Mukai, Shimpei Fujimoto, Nobuya Inagaki

    Vydáno 2022
    Získat plný text Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  8. 8
    Pharmacokinetics, Pharmacodynamics, and Safety of Canagliflozin in Japanese Patients with Type 2 Diabetes Mellitus

    Pharmacokinetics, Pharmacodynamics, and Safety of Canagliflozin in Japanese Patients with Type 2 Diabetes Mellitus Autor Hiroaki Iijima, Takayuki Kifuji, Nobuko Maruyama, Nobuya Inagaki

    Vydáno 2015
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  9. 9
    Efficacy and safety of canagliflozin alone or as add‐on to other oral antihyperglycemic drugs in Japanese patients with type 2 diabetes: A 52‐week open‐label study

    Efficacy and safety of canagliflozin alone or as add‐on to other oral antihyperglycemic drugs in Japanese patients with type 2 diabetes: A 52‐week open‐label study Autor Nobuya Inagaki, Kazuoki Kondo, Toru Yoshinari, Hideki Kuki

    Vydáno 2014
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  10. 10
    Characterization and Classification of ATP-binding Cassette Transporter ABCA3 Mutants in Fatal Surfactant Deficiency

    Characterization and Classification of ATP-binding Cassette Transporter ABCA3 Mutants in Fatal Surfactant Deficiency Autor Yoshihiro Matsumura, Nobuhiro Ban, Kazumitsu Ueda, Nobuya Inagaki

    Vydáno 2006
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  11. 11
    <scp>iPSC</scp> technology‐based regenerative therapy for diabetes

    <scp>iPSC</scp> technology‐based regenerative therapy for diabetes Autor Yasushi Kondo, Tarō Toyoda, Nobuya Inagaki, Kenji Osafune

    Vydáno 2017
    Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  12. 12
    c-Jun represses the human insulin promoter activity that depends on multiple cAMP response elements.

    c-Jun represses the human insulin promoter activity that depends on multiple cAMP response elements. Autor Nobuya Inagaki, Tomoko Maekawa, T Sudo, Shunsuke Ishii, Yutaka Seino, Hiroo Imura

    Vydáno 1992
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  13. 13
    Synaptotagmin III is a novel isoform of rat synaptotagmin expressed in endocrine and neuronal cells.

    Synaptotagmin III is a novel isoform of rat synaptotagmin expressed in endocrine and neuronal cells. Autor Masanari Mizuta, Nobuya Inagaki, Y Nemoto, Shigeru Matsukura, Masayuki Takahashi, Susumu Seino

    Vydáno 1994
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  14. 14
    Efficacy and safety of once‐weekly dulaglutide in combination with sulphonylurea and/or biguanide compared with once‐daily insulin glargine in <scp>J</scp>apanese patients with type 2 diabetes: a randomized, open‐label, phase <scp>III</scp>, non‐inferiority study

    Efficacy and safety of once‐weekly dulaglutide in combination with sulphonylurea and/or biguanide compared with once‐daily insulin glargine in <scp>J</scp>apanese patients with typ... Autor Eiichi Araki, Nobuya Inagaki, Yukio Tanizawa, Tomonori Oura, Masakazu Takeuchi, Takeshi Imaoka

    Vydáno 2015
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  15. 15
    Measurement of Glucose Uptake and Intracellular Calcium Concentration in Single, Living Pancreatic β-Cells

    Measurement of Glucose Uptake and Intracellular Calcium Concentration in Single, Living Pancreatic β-Cells Autor Katsuya Yamada, Masanori Nakata, Naoki Horimoto, Mikako Saito, Hideaki Matsuoka, Nobuya Inagaki

    Vydáno 2000
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  16. 16
    Efficacy and safety of canagliflozin in Japanese patients with type 2 diabetes: a randomized, double‐blind, placebo‐controlled, 12‐week study

    Efficacy and safety of canagliflozin in Japanese patients with type 2 diabetes: a randomized, double‐blind, placebo‐controlled, 12‐week study Autor Nobuya Inagaki, Kazuoki Kondo, Toru Yoshinari, Nobuko Maruyama, Yutaka Susuta, Hideki Kuki

    Vydáno 2013
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  17. 17
    Cellular localization of synaptotagmin I, II, and III mRNAs in the central nervous system and pituitary and adrenal glands of the rat

    Cellular localization of synaptotagmin I, II, and III mRNAs in the central nervous system and pituitary and adrenal glands of the rat Autor Béatrice Marquèze‐Pouey, JA Boudier, Masanari Mizuta, Nobuya Inagaki, Susumu Seino, Michael Seagar

    Vydáno 1995
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  18. 18
    Efficacy and safety of canagliflozin in combination with insulin: a double-blind, randomized, placebo-controlled study in Japanese patients with type 2 diabetes mellitus

    Efficacy and safety of canagliflozin in combination with insulin: a double-blind, randomized, placebo-controlled study in Japanese patients with type 2 diabetes mellitus Autor Nobuya Inagaki, Shin‐ichi Harashima, Nobuko Maruyama, Yutaka Kawaguchi, Maki Goda, Hiroaki Iijima

    Vydáno 2016
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  19. 19
    Intra‐ and inter‐subject variability for increases in serum ketone bodies in patients with type 2 diabetes treated with the sodium glucose co‐transporter 2 inhibitor canagliflozin

    Intra‐ and inter‐subject variability for increases in serum ketone bodies in patients with type 2 diabetes treated with the sodium glucose co‐transporter 2 inhibitor canagliflozin... Autor David Polidori, Hiroaki Iijima, Maki Goda, Nobuko Maruyama, Nobuya Inagaki, Peter A. Crawford

    Vydáno 2018
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  20. 20
    Disruption of TBP-2 ameliorates insulin sensitivity and secretion without affecting obesity

    Disruption of TBP-2 ameliorates insulin sensitivity and secretion without affecting obesity Autor Eiji Yoshihara, Shimpei Fujimoto, Nobuya Inagaki, Katsuya Okawa, So Masaki, Junji Yodoi, Hiroshi Masutani

    Vydáno 2010
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:

Vyhledávací nástroje: